TNFSF4 and neoplasm: A low dose of the armed oncolytic virus OV-OX40L/IL12 was injected into tumors to convert tumor cells into artificial APCs in situ prior to the adoptive transfer of TILs as a method to augment tumor-specific T cell expansion and antitumor activities.